# Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-iii-study-comparing-tacrolimus-fk506-with-cyclosporine-for-graft-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | A Hiraoka,Yasuo Ohashi,Shinichiro Okamoto,Y Moriyama,T Nagao,Y Kodera,A Kanamaru,Hiroo Dohy,T Masaoka |
| Citations | 156 |
| DOI | 10.1038/sj.bmt.1703097 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nature.com/articles/1703097.pdf |
| OpenAlex ID | https://openalex.org/W2056337106 |
| PMID | 11509936 |
| Type | article |
| Year | 2001 |

## Paper authors

- [Shinichiro Okamoto](https://scholariq.org/researchers/shinichiro-okamoto/)

## Paper primary topic

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)

## Paper topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.